drugset / Trial / NCT01080820
A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to evaluate the safety and tolerability of CMX157 and the amount of CMX157 that reaches the blood stream, the manner in which the body processes CMX157 and the time that it takes to eliminate CMX157 following one oral dose when given to healthy volunteers.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenofovir Exalidex | Other / unclassified | — | Oral |
| Background | Tenofovir disoproxil fumarate | Small molecule | 300 mg | Oral |
Indications
No indication recorded.